| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1517/14712598.2010.500284 |
| P698 | PubMed publication ID | 20560782 |
| P2093 | author name string | Seung Duk Hwang | |
| Jin Kuk Kim | |||
| Soo Jeong Choi | |||
| P2860 | cites work | Isolation and characterization of multipotent progenitor cells from the Bowman's capsule of adult human kidneys | Q24298682 |
| The renal papilla is a niche for adult kidney stem cells | Q24562153 | ||
| Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors | Q27860937 | ||
| Induction of pluripotent stem cells from adult human fibroblasts by defined factors | Q27860967 | ||
| Bone morphogenic protein-7 inhibits progression of chronic renal fibrosis associated with two genetic mouse models | Q28201247 | ||
| Origins and formation of microvasculature in the developing kidney | Q28282271 | ||
| Isolation of putative progenitor endothelial cells for angiogenesis | Q28302884 | ||
| HMG-CoA reductase inhibitor mobilizes bone marrow--derived endothelial progenitor cells | Q28345589 | ||
| Evidence that fibroblasts derive from epithelium during tissue fibrosis | Q29616581 | ||
| Mesenchymal stem cells reside in virtually all post-natal organs and tissues | Q29617740 | ||
| Human mesenchymal stem cells in rodent whole-embryo culture are reprogrammed to contribute to kidney tissues | Q30856630 | ||
| Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial | Q31033745 | ||
| Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms | Q31147648 | ||
| Branching ducts similar to mesonephric ducts or ureteric buds in teratomas originating from mouse embryonic stem cells | Q33221866 | ||
| Restoration of tubular epithelial cells during repair of the postischemic kidney occurs independently of bone marrow-derived stem cells | Q33865856 | ||
| Cellular and molecular mediators in common pathway mechanisms of chronic renal disease progression | Q33991001 | ||
| Kidney tubular epithelium is restored without replacement with bone marrow-derived cells during repair after ischemic injury | Q34042110 | ||
| RENAL HETEROTRANSPLANTATION FROM BABOON TO MAN: EXPERIENCE WITH 6 CASES | Q34275814 | ||
| Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial | Q34332467 | ||
| Culture systems for pluripotent stem cells | Q34460767 | ||
| Generation of histocompatible tissues using nuclear transplantation. | Q34524710 | ||
| TGF-beta signaling in renal disease | Q34869314 | ||
| Autologous and allogeneic marrow stromal cells are safe and effective for the treatment of acute kidney injury | Q35304596 | ||
| The role of epithelial-to-mesenchymal transition in renal fibrosis | Q35643525 | ||
| Xenotransplantation and the future of renal replacement. | Q35752249 | ||
| Embryonic committed stem cells as a solution to kidney donor shortage | Q35753500 | ||
| Apoptosis in podocytes induced by TGF-beta and Smad7 | Q36041187 | ||
| Immunobiology of human mesenchymal stem cells and future use in hematopoietic stem cell transplantation | Q36104468 | ||
| Musculin/MyoR is expressed in kidney side population cells and can regulate their function | Q36321197 | ||
| Stromal cells protect against acute tubular injury via an endocrine effect. | Q50950182 | ||
| Tissue engineered ceramic artificial joint--ex vivo osteogenic differentiation of patient mesenchymal cells on total ankle joints for treatment of osteoarthritis. | Q51538382 | ||
| Bone marrow-derived cells contribute to podocyte regeneration and amelioration of renal disease in a mouse model of Alport syndrome. | Q51793488 | ||
| Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. | Q52008649 | ||
| Perivascular niche of postnatal mesenchymal stem cells in human bone marrow and dental pulp. | Q52107163 | ||
| Lineage-negative bone marrow cells protect against chronic renal failure. | Q53429732 | ||
| Mesenchymal stem cells prevent progressive experimental renal failure but maldifferentiate into glomerular adipocytes. | Q53557183 | ||
| Transplanted mesenchymal stem cells accelerate glomerular healing in experimental glomerulonephritis. | Q53616452 | ||
| Erythropoietin regulates endothelial progenitor cells | Q53854344 | ||
| Mesenchymal cells from adult kidney support angiogenesis and differentiate into multiple interstitial cell types including erythropoietin-producing fibroblasts. | Q54607688 | ||
| Human and porcine early kidney precursors as a new source for transplantation | Q57233878 | ||
| Acute renal failure in hematopoietic cell transplantation | Q36361583 | ||
| Toward a unified theory of renal progression | Q36366880 | ||
| Cellular therapies for kidney failure | Q36377192 | ||
| Insulin stimulates the clonogenic potential of angiogenic endothelial progenitor cells by IGF-1 receptor-dependent signaling | Q36479917 | ||
| Mesenchymal stem cells: immunobiology and therapeutic potential in kidney disease | Q36734065 | ||
| The contribution of adult stem cells to renal repair | Q36769490 | ||
| The therapeutic potential of mesenchymal stem cells. Cell- & tissue-based therapy | Q36897375 | ||
| Erythropoietin expands a stromal cell population that can mediate renoprotection | Q36956699 | ||
| Nocturnal hemodialysis improves erythropoietin responsiveness and growth of hematopoietic stem cells | Q37123278 | ||
| Kidney-derived stromal cells modulate dendritic and T cell responses | Q37146453 | ||
| Kidney regeneration by xeno-embryonic nephrogenesis | Q37159374 | ||
| Mesenchymal stem cell-derived microvesicles protect against acute tubular injury | Q37176871 | ||
| Kidney organogenesis and regeneration: a new era in the treatment of chronic renal failure? | Q37201506 | ||
| Stem cells for kidney repair: useful tool for acute renal failure? | Q37270402 | ||
| Kidney-derived mesenchymal stem cells contribute to vasculogenesis, angiogenesis and endothelial repair | Q37435235 | ||
| Overview of stem cell therapy for Crohn's disease. | Q37519645 | ||
| Role of basic fibroblast growth factor-2 in epithelial-mesenchymal transformation | Q38289991 | ||
| Characterization and functionality of cell surface molecules on human mesenchymal stem cells | Q38357443 | ||
| Low circulating CD34+ cell count is associated with poor prognosis in chronic hemodialysis patients. | Q40037882 | ||
| Xenobiotic kidney organogenesis from human mesenchymal stem cells using a growing rodent embryo | Q40307421 | ||
| Wnt4-transformed mouse embryonic stem cells differentiate into renal tubular cells | Q40378282 | ||
| Multipotent mesenchymal stem cells reduce interstitial fibrosis but do not delay progression of chronic kidney disease in collagen4A3-deficient mice. | Q42495926 | ||
| A role for uric acid in the progression of renal disease | Q44223958 | ||
| Hematopoietic stem cells contribute to the regeneration of renal tubules after renal ischemia-reperfusion injury in mice. | Q44411519 | ||
| Improvement in endothelial progenitor cells from peripheral blood by ramipril therapy in patients with stable coronary artery disease | Q44960467 | ||
| Intrarenal injection of bone marrow-derived angiogenic cells reduces endothelial injury and mesangial cell activation in experimental glomerulonephritis | Q45295903 | ||
| Mesenchymal stem cells delivered at the subcapsule of the kidney ameliorate renal disease in the rat remnant kidney model. | Q45832624 | ||
| Erythropoietin delivery by genetically engineered bone marrow stromal cells for correction of anemia in mice with chronic renal failure. | Q45857983 | ||
| Clinical responses to bone marrow transplantation in children with severe osteogenesis imperfecta | Q45875073 | ||
| Current status of kidney and pancreas transplantation in the United States, 1994-2003. | Q46465681 | ||
| The role of mesenchymal stem cells in the functional improvement of chronic renal failure | Q46469071 | ||
| Effect of whole bone marrow cell infusion in the progression of experimental chronic renal failure. | Q46613204 | ||
| Mesenchymal stem cells induce apoptosis of activated T cells | Q46622786 | ||
| Losartan improves the impaired function of endothelial progenitor cells in hypertension via an antioxidant effect | Q46771474 | ||
| Mesenchymal stem cells are renotropic, helping to repair the kidney and improve function in acute renal failure | Q47302183 | ||
| Effects of mesenchymal stem cells on differentiation, maturation, and function of human monocyte-derived dendritic cells | Q47372947 | ||
| Treatment of enterocutaneous fistula in Crohn's Disease with adipose-derived stem cells: a comparison of protocols with and without cell expansion | Q47403441 | ||
| Decreased number and impaired angiogenic function of endothelial progenitor cells in patients with chronic renal failure | Q47449596 | ||
| Life-supporting pig-to-primate renal xenotransplantation using genetically modified donors | Q47842680 | ||
| Isolation and characterization of resident mesenchymal stem cells in human glomeruli. | Q50738993 | ||
| Integration of embryonic stem cells in metanephric kidney organ culture. | Q50769403 | ||
| Chondrogenic and adipogenic potential of microvascular pericytes. | Q50784818 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | mesenchymal stem cell | Q1922379 |
| P304 | page(s) | 1217-1226 | |
| P577 | publication date | 2010-08-01 | |
| P1433 | published in | Expert Opinion on Biological Therapy | Q5421201 |
| P1476 | title | Mesenchymal stem cell therapy for chronic renal failure | |
| P478 | volume | 10 |
| Q83348681 | Age related changes of the extracellular matrix and stem cell maintenance |
| Q26864966 | Bioengineering kidneys for transplantation |
| Q51053705 | Bone Marrow-Derived Mesenchymal Stem Cells and Their Conditioned Medium Attenuate Fibrosis in an Irreversible Model of Unilateral Ureteral Obstruction. |
| Q59329757 | Bone marrow mesenchymal stem cells attenuate the progression of focal segmental glomerulosclerosis in rat models |
| Q26866578 | Cell-based therapies for experimental chronic kidney disease: a systematic review and meta-analysis |
| Q55001401 | Co-Administration of Melatonin Effectively Enhances the Therapeutic Effects of Pioglitazone on Mesenchymal Stem Cells Undergoing Indoxyl Sulfate-Induced Senescence through Modulation of Cellular Prion Protein Expression. |
| Q36099800 | Detrimental effects of rat mesenchymal stromal cell pre-treatment in a model of acute kidney rejection |
| Q33919335 | Extracellular vesicles released from mesenchymal stromal cells modulate miRNA in renal tubular cells and inhibit ATP depletion injury |
| Q28728256 | Human embryonic mesenchymal stem cell-derived conditioned medium rescues kidney function in rats with established chronic kidney disease |
| Q35747607 | Influence of erythropoietin on microvesicles derived from mesenchymal stem cells protecting renal function of chronic kidney disease |
| Q37011969 | Mesenchymal stem cell therapy promotes the improvement and recovery of renal function in a preclinical model. |
| Q38599408 | Mesenchymal stem cells as novel micro-ribonucleic acid delivery vehicles in kidney disease |
| Q35240668 | Mesenchymal stem cells: from experiment to clinic |
| Q42177069 | Phenotypic characterizations and comparison of adult dental stem cells with adipose-derived stem cells |
| Q37968803 | Repairing the chronic damaged kidney: the role of regenerative medicine. |
| Q42393097 | SDF-1:CXCR4 Axis Is Fundamental for Tissue Preservation and Repair |
| Q36998733 | Safety and efficacy of intravenous infusion of allogeneic cryopreserved mesenchymal stem cells for treatment of chronic kidney disease in cats: results of three sequential pilot studies |
| Q52776165 | Significant curative functions of the mesenchymal stem cells on methotrexate-induced kidney and liver injuries in rats. |
| Q51072947 | Transplantation of bone marrow-derived MSCs improves renal function and Na++K+-ATPase activity in rats with renovascular hypertension. |
| Q26751470 | Update on the treatment of focal segmental glomerulosclerosis in renal transplantation |
Search more.